Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2026 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2026 | 1 | -$0.40 | -$0.40 | -$0.40 |
| Q4 2026 | 1 | -$0.40 | -$0.40 | -$0.40 |
Creative Medical Technology Holdings Inc last posted its earnings results on Friday, May 8th, 2026. The company reported $-0.38 earnings per share for the quarter, topping analysts' consensus estimates of $-0.39 by $0.01. The company had revenue of 0 for the quarter and had revenue of 6.00 K for the year. Creative Medical Technology Holdings Inc has generated $-3 earnings per share over the last year ($-2.52 diluted earnings per share) and currently has a price-to-earnings ratio of -1.42. Creative Medical Technology Holdings Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/08/2026 | Q1 2026 | -$0.39 | -$0.38 | 0.01 | $0 | $0 |
| 03/20/2026 | Q4 2025 | -$0.37 | -$0.73 | -0.36 | $3.00 K | $3.00 K |
| 11/07/2025 | Q3 2025 | -$0.48 | -$0.48 | 0 | $0 | $0 |
| 08/08/2025 | Q2 2025 | -$0.63 | -$0.48 | 0.15 | N/A | $0 |
| 05/09/2025 | Q1 2025 | -$0.52 | -$0.83 | -0.31 | N/A | $3.00 K |
| 03/14/2025 | Q4 2024 | -$0.63 | -$1.12 | -0.49 | N/A | $3.00 K |
| 11/08/2024 | Q3 2024 | -$0.85 | -$0.75 | 0.1 | N/A | $0 |
| 08/09/2024 | Q2 2024 | -$0.84 | -$1.11 | -0.27 | N/A | $8.00 K |
| 05/10/2024 | Q1 2024 | -$1.15 | -$0.73 | 0.42 | N/A | $0 |
| 03/22/2024 | Q4 2023 | -$1.13 | -$1.21 | -0.08 | N/A | $3.00 K |
| 11/14/2023 | Q3 2023 | -$0.86 | -$1.02 | -0.16 | N/A | $6.00 K |
| 08/11/2023 | Q2 2023 | -$0.83 | -$0.78 | 0.05 | N/A | $0 |
| 05/12/2023 | Q1 2023 | -$1.00 | -$0.70 | 0.3 | N/A | $0 |
| 05/01/2023 | Q4 2022 | N/A | -$4.37 | N/A | N/A | $18.60 K |
| 11/10/2022 | Q3 2022 | -$0.13 | -$0.70 | -0.57 | N/A | $55.00 K |
| 08/12/2022 | Q2 2022 | -$0.15 | -$2.25 | -2.1 | N/A | $0 |
| 05/13/2022 | Q1 2022 | -$0.14 | -$1.79 | -1.65 | N/A | $15.00 K |
| 03/30/2022 | Q4 2021 | -$0.23 | -$11.13 | -10.9 | N/A | $67.75 K |
| 11/15/2021 | Q3 2021 | N/A | -$7.52 | N/A | N/A | $10.00 K |
| 08/16/2021 | Q2 2021 | N/A | -$12.52 | N/A | N/A | $10.00 K |
In the previous quarter, Creative Medical Technology Holdings Inc (:CELZ) reported $-0.38 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.39 by $0.01.
The conference call for Creative Medical Technology Holdings Inc's latest earnings report can be listened to online.
The conference call transcript for Creative Medical Technology Holdings Inc's latest earnings report can be read online.
Creative Medical Technology Holdings Inc (:CELZ) has a recorded annual revenue of $6.00 K.
Creative Medical Technology Holdings Inc (:CELZ) has a recorded net income of $-5,995,008.Creative Medical Technology Holdings Inc has generated $-2.52 earnings per share over the last four quarters.
Creative Medical Technology Holdings Inc (:CELZ) has a price-to-earnings ratio of -1.42 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED